MedTrace Logo

Cognitive and Blood Flow Effects of Mountain Tea

NCT03475823 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 155

Last updated 2018-03-23

No results posted yet for this study

Summary

Two doses (475 mg and 950 mg) of Sideritis Scardica (SS or 'mountain tea') are investigated for cognitive, mood, blood pressure and cerebral blood flow effects in a healthy group of 50-70 yr olds, both acutely and following 28 days of consumption.

Conditions

  • Cognitive Change
  • Affect
  • Blood Pressure
  • Neuroimaging

Interventions

DIETARY_SUPPLEMENT

Sideritis Scardica

Sideritis Scardica is a popular, naturally un-caffeinated Eastern European tea extract derived from the ironwort plant

DIETARY_SUPPLEMENT

Ginkgo biloba

Ginkgo biloba is an extract from the ginkgo tree comprising ginkgolides and bilobalide. In this trial Ginkgo acted as an active control.

DIETARY_SUPPLEMENT

Placebo control

An inert encapsulated powder provided by Finzelberg.

Sponsors & Collaborators

  • Finzelberg

    collaborator UNKNOWN

  • Northumbria University

    lead OTHER

Principal Investigators

  • Emma L Wightman, PhD · Northumbria University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-02-17
Primary Completion
2017-09-18
Completion
2017-09-18

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03475823 on ClinicalTrials.gov